Great Bay Bio 大湾生物
San Francisco Bay Area, China · Founded 2019 · $28.8M raised
- Headquarters
- San Francisco Bay Area
- Employees
- 51–200
- Founded
- 2019
- Business Model
- B2B
- Website
- greatbay-bio.com
- Total Funding
- $28.8M
- Last Round
- $15.0M Series BDec 2024
- Rounds
- 3
About
Great Bay Bio is a San Diego-based bioanalytical services company providing rapid, ultrasensitive protein characterization for drug development. Founded in 2020, it offers specialized CRO services including biomarker discovery, assay development, and analytical testing to support biopharmaceutical clients through the drug development lifecycle.
Summary
Great Bay Bio 大湾生物 is an Artificial Intelligence company based in San Francisco Bay Area, China, founded in 2019. It has raised $28.8M in total across 3 rounds, most recently a $15.0M Series B round in Dec 2024. Investors include Tiger Jade Capital, Proxima Ventures and Alibaba Entrepreneurs Fund.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...